• Home
  • Search Results
  • Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.

Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.

Bioanalysis (2014-11-12)
Nynke G L Jager, Hilde Rosing, Jan H M Schellens, Jos H Beijnen
ABSTRACT

Dried blood spot (DBS) sampling, the collection of whole blood samples on paper, is an emerging technique used for bioanalytical methods. Several analytical challenges, such as possible effects of spotting volume, hematocrit and spot inhomogeneity are identified for these methods, however, no regulatory-based guidelines for the specific validation of DBS-based assays are available hitherto. To date, 68 validation reports concerning methods for the quantitative determination of drugs in human DBS could be traced in the literature, with large differences in the extensiveness of the reported validations. This review aims to present an overview of these published validations. Additionally, the different challenges of DBS-based assays are discussed and recommendations on how to perform validation tests addressing these challenges are provided.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dexamethasone, powder, BioReagent, suitable for cell culture, ≥97%
Supelco
Acetaminophen, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Dexamethasone, ≥98% (HPLC), powder
Sigma-Aldrich
Acetaminophen, BioXtra, ≥99.0%
Supelco
Metronidazole, analytical standard
Sigma-Aldrich
Acetaminophen, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
Carbamazepine, powder
Sigma-Aldrich
Acetaminophen, analytical standard
Paracetamol, European Pharmacopoeia (EP) Reference Standard
Supelco
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Dexamethasone, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
Metronidazole, BioXtra
Supelco
Metronidazole, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Acetaminophen, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Clarithromycin, ≥95% (HPLC)
Supelco
Posaconazole, VETRANAL®, analytical standard
Supelco
Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ritonavir, ≥98% (HPLC)
Supelco
Carbamazepine, analytical standard
Supelco
Metronidazole, VETRANAL®, analytical standard
Sigma-Aldrich
Dexamethasone, meets USP testing specifications
Sigma-Aldrich
Darunavir, ≥98% (HPLC)
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Efavirenz, ≥98% (HPLC)
USP
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Clarithromycin, 96.0-102.0% (HPLC)
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
Clarithromycin, European Pharmacopoeia (EP) Reference Standard